Donald M Jr. Casey
CIK 1423197 · President & CEO · last filed 2022-04-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$46.63M
Companies
5
Total Filings
68
Lifetime Open-Market Net
-$3.25M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XRAY | President & CEO | 268,005 | $13.76 | $3.69M | $2.53M | 37 | 2022-04-11 |
| CAH | CEO, Medical Segment | 146,503 | $227.47 | $33.33M | -$4.95M | 17 | 2017-09-18 |
| WEST CORP (WSTC) Delisted | Director | 8,559 | — | — | $0 | 2 | 2016-12-16 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Director | 99 | — | — | $0 | 6 | 2012-03-09 |
| JNJ | Member, Executive Committee | 37,658 | $255.44 | $9.62M | -$837.4K | 5 | 2009-09-14 |
Recent Filings · Page 6 of 7
68 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-09-16 | CAH | Grant (A) | +20,011 | $0 | EDGAR |
| 2014-08-19 | CAH | Mixed | +8,373 | -$209.0K | EDGAR |
| 2014-08-07 | CAH | Grant (A) | +14,785 | $0 | EDGAR |
| 2013-08-19 | CAH | Mixed | +14,597 | -$18.6K | EDGAR |
| 2013-04-17 | CAH | Tax (F) | −249 | -$10.7K | EDGAR |
| 2012-08-17 | CAH | Grant (A) | +17,584 | $0 | EDGAR |
| 2012-04-18 | CAH | Grant (A) | +12,321 | $0 | EDGAR |
| 2012-03-09 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-10-04 | ALBIREO PHARMA, INC. (BIOD) Delisted | Exer (M) | +1,969 | $0 | EDGAR |
| 2011-04-20 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.